Qian Xu

机构：Fifth Affiliated Hospital of Zhengzhou University · ORCID：0000-0001-7061-7282

发表论文 129 篇 · 总被引 2119 次 · h-index 24

代表论文

• Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study (2024 · BMC Medicine · 被引 15)
• Disitamab vedotin (RC48), tislelizumab, and S-1 as first-line therapy for HER2-overexpressing advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results from the RCTS trial. (2025 · Journal of Clinical Oncology · 被引 8)
• Effectiveness of E‐Health Interventions on Improving Physical Activity in Pregnant Women: A Systematic Review and Meta‐Analysis (2025 · Journal of Clinical Nursing · 被引 6)
• Dietary inflammatory index and its associations with cardiovascular diseases and cancer: Evidence form NHANES 2017–2018 and Mendelian randomization analysis (2024 · Experimental Gerontology · 被引 5)
• Polyunsaturated fatty acids may not be helpful for people with osteoarthritis: a two-sample Mendelian randomization analysis (2025 · Scientific Reports · 被引 4)
• The effects of GLUT9 and URAT1 inhibitors on cardiovascular diseases: a drug-targeted Mendelian randomization study (2025 · International Urology and Nephrology · 被引 3)